COVID-19 pandemic Mexican health regulator COFEPRIS approves the emergency use of Eli Lilly and Co's injectable combination of bamlanivimab and etesevimab to treat mild to moderate COVID-19 cases in people over the age of 12 years who weigh at least 40 kg. Mexico approves emergency use of Lilly's COVID-19 treatment © Reuters Sources: Reuters
